PUBLISHER: IMARC | PRODUCT CODE: 1722764
PUBLISHER: IMARC | PRODUCT CODE: 1722764
The global probiotic ingredients market size reached USD 5.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.99% during 2025-2033. The growing consumer inclination towards improving gut health and overall well-being is stimulating the market.
Probiotics refer to live microorganisms consumed for improving the functioning of the digestive system. Also known as good or healthy bacteria, they help prevent diseases related to oral health, bacterial vaginosis, and urinary tract infection. They also aid in preventing ailments such as respiratory infections, necrotizing enterocolitis, and bowel diseases. Probiotic ingredients are available in the form of capsules, tablets, powder, and liquid, as well as found in fermented food products containing live-active cultures, such as yogurt, kefir, sourdough bread, sauerkraut, tempeh, and kimchi. When consumed in the form of supplements, probiotics colonize the gut with health-boosting microorganisms and stops undesirable bacteria from overgrowing in the digestive tract. They are also suggested by doctors as they help in reducing depression and promote heart health.
The global probiotic ingredients market is primarily driven by the increasing awareness among individuals regarding preventive healthcare, which has resulted in the rising expenditure on probiotic products. This trend has further been boosted by the spread of the coronavirus disease (COVID-19) pandemic, which has increased the focus toward strengthening immunity. The growing prevalence of gut-related diseases, especially among the geriatric population, is also propelling the market growth. In countries such as Japan, Germany, and the United States, probiotic-based dietary supplements are widely consumed, and probiotic food products have become a part of the food culture. Factors such as increasing disposable incomes and the changing attitude toward preventive healthcare, coupled with the easy availability of information on the internet, are positively influencing the growth of the market. Furthermore, market players are launching new products in convenient packaging formats made with superior quality ingredients.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzyme Technologies Limited, Biena, Biogaia, Chr. Hansen Holding AS, Danone Inc., Deerland Probiotics & Enzymes Inc., DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM NV and Lallemand Inc.